top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SGMO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,000,000.00

Sangamo Therapeutics Insider Trading History Chart

Sangamo Therapeutics Share Price & Price History

^$0.49

▼ -0.03 (-5.74%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Sangamo Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/26/2023	Biogen Inc.	Major Shareholder	Sell	6,000,000	$0.50	$3,000,000.00	17,652,466
8/29/2022	Biogen Inc.	Major Shareholder	Sell	400,000	$5.33	$2,132,000.00	23,752,466
6/3/2022	John Markels	Director	Buy	6,784	$3.69	$25,032.96	32,484
12/27/2021	Biogen Inc.	Major Shareholder	Sell	600	$8.56	$5,136.00
12/23/2021	Biogen Inc.	Major Shareholder	Sell	81,187	$8.55	$694,148.85
12/9/2021	Biogen Inc.	Major Shareholder	Sell	23,660	$8.56	$202,529.60
12/7/2021	Biogen Inc.	Major Shareholder	Sell	52,178	$8.52	$444,556.56
11/26/2021	Biogen Inc.	Major Shareholder	Sell	28,884	$8.60	$248,402.40

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for Sangamo Therapeutics (NASDAQ:SGMO)

56.93% of Sangamo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sangamo Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Wasatch Advisors LP	20,132,324	$13.49M	0.1%	+62.4%	11.253%
2/14/2024	Wasatch Advisors LP	12,397,924	$6.74M	0.0%	-31.1%	6.991%
2/2/2024	Golden State Equity Partners	201,225	$0.11M	0.0%	+21.0%	0.113%
1/31/2024	Federated Hermes Inc.	340,693	$0.19M	0.0%	-23.3%	0.192%
1/30/2024	Mackenzie Financial Corp	73,799	$40K	0.0%	+72.4%	0.042%
1/17/2024	Assenagon Asset Management S.A.	1,033,322	$0.56M	0.0%	+14.4%	0.583%
1/12/2024	SG Americas Securities LLC	180,544	$98K	0.0%	+103.9%	0.102%
12/19/2023	Public Employees Retirement System of Ohio	50,200	$30K	0.0%	-86.2%	0.028%
12/7/2023	Hudson Bay Capital Management LP	1,298,500	$0.78M	0.0%	-2.0%	0.732%
11/13/2023	Acadian Asset Management LLC	2,927,769	$1.75M	0.0%	+3.7%	1.651%
11/8/2023	Vanguard Personalized Indexing Management LLC	43,057	$26K	0.0%	N/A	0.024%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	676,189	$0.41M	0.0%	+10.2%	0.382%
10/25/2023	Miracle Mile Advisors LLC	41,300	$25K	0.0%	N/A	0.023%
10/20/2023	Golden State Equity Partners	166,265	$100K	0.0%	+22.5%	0.094%
10/17/2023	DAVENPORT & Co LLC	47,100	$28K	0.0%	-31.0%	0.027%
10/13/2023	SG Americas Securities LLC	88,542	$53K	0.0%	+255.2%	0.050%
8/14/2023	Graham Capital Management L.P.	67,748	$88K	0.0%	N/A	0.038%
8/11/2023	Penserra Capital Management LLC	99,352	$0.13M	0.0%	+163.5%	0.056%
8/11/2023	ExodusPoint Capital Management LP	2,083,633	$2.71M	0.0%	+59.1%	1.176%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	613,724	$0.80M	0.0%	+16.8%	0.357%
8/8/2023	Wasatch Advisors LP	17,052,440	$22.17M	0.1%	+25.0%	9.924%
8/7/2023	Principal Financial Group Inc.	50,889	$66K	0.0%	+30.1%	0.030%
8/7/2023	Acadian Asset Management LLC	2,821,980	$3.67M	0.0%	+502.7%	1.642%
8/3/2023	Mackenzie Financial Corp	30,568	$41K	0.0%	N/A	0.018%
8/1/2023	Fort Sheridan Advisors LLC	66,486	$86K	0.0%	+15.0%	0.039%
8/1/2023	Cookson Peirce & Co. Inc.	50,000	$65K	0.0%	N/A	0.029%
7/25/2023	Raymond James Financial Services Advisors Inc.	40,103	$52K	0.0%	-46.0%	0.023%
7/24/2023	Allspring Global Investments Holdings LLC	46,408	$60K	0.0%	+278.8%	0.027%
7/24/2023	Vontobel Holding Ltd.	30,560	$40K	0.0%	-56.7%	0.018%
7/20/2023	DAVENPORT & Co LLC	68,300	$89K	0.0%	-12.4%	0.040%
7/18/2023	Diversified Trust Co	25,740	$33K	0.0%	N/A	0.015%
7/18/2023	Allspring Global Investments Holdings LLC	46,408	$60K	0.0%	+278.8%	0.027%
7/10/2023	SG Americas Securities LLC	24,930	$32K	0.0%	-66.4%	0.015%
6/1/2023	Golden State Equity Partners	135,765	$0.24M	0.1%	N/A	0.079%
5/12/2023	Long Focus Capital Management LLC	639,372	$1.13M	0.1%	-40.4%	0.372%
5/12/2023	Rhenman & Partners Asset Management AB	314,157	$0.53M	0.1%	-61.7%	0.183%
5/11/2023	Acadian Asset Management LLC	468,239	$0.82M	0.0%	N/A	0.273%
5/11/2023	Cornercap Investment Counsel Inc.	86,934	$0.15M	0.0%	+28.0%	0.051%
5/11/2023	ExodusPoint Capital Management LP	1,309,323	$2.30M	0.0%	+496.5%	0.762%
5/10/2023	Credit Suisse AG	3,819,113	$6.72M	0.0%	+0.3%	2.227%
5/9/2023	Russell Investments Group Ltd.	195,906	$0.35M	0.0%	+93.3%	0.114%
5/8/2023	Federated Hermes Inc.	320,036	$0.56M	0.0%	+126.1%	0.187%
5/4/2023	Barclays PLC	379,016	$0.67M	0.0%	-24.0%	0.221%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	525,280	$0.92M	0.0%	+5.6%	0.306%
5/1/2023	Banque Pictet & Cie SA	85,944	$0.15M	0.0%	-31.2%	0.050%
4/28/2023	SG Americas Securities LLC	74,156	$0.13M	0.0%	+42.3%	0.043%
4/19/2023	Nordea Investment Management AB	640,346	$1.11M	0.0%	-4.9%	0.373%
4/18/2023	Assenagon Asset Management S.A.	903,547	$1.59M	0.0%	+4.5%	0.527%
3/28/2023	Acrisure Capital Management LLC	31,673	$99K	0.1%	N/A	0.019%
3/23/2023	MetLife Investment Management LLC	55,073	$0.17M	0.0%	-17.6%	0.033%
2/15/2023	Avidity Partners Management LP	2,748,300	$8.63M	0.2%	+16.4%	1.677%
2/13/2023	Pinnacle Wealth Planning Services Inc.	14,386	$45K	0.0%	-40.3%	0.009%
2/13/2023	Credit Suisse AG	3,808,146	$11.96M	0.0%	+0.1%	2.324%
2/13/2023	GSA Capital Partners LLP	200,465	$0.63M	0.1%	+1,232.0%	0.122%
2/13/2023	Cornercap Investment Counsel Inc.	67,910	$0.21M	0.0%	+34.8%	0.041%
2/13/2023	Quadrant Capital Group LLC	12,734	$40K	0.0%	+848.9%	0.008%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	349,894	$1.10M	0.0%	-42.2%	0.214%
2/10/2023	Blair William & Co. IL	294,902	$0.93M	0.0%	-14.5%	0.180%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	497,306	$1.56M	0.0%	-21.8%	0.303%
2/9/2023	Citigroup Inc.	339,575	$1.07M	0.0%	-14.5%	0.207%
2/9/2023	HighTower Advisors LLC	1,030,958	$3.24M	0.0%	-11.3%	0.629%
2/8/2023	Raymond James Financial Services Advisors Inc.	80,083	$0.25M	0.0%	-5.0%	0.049%
2/8/2023	UBS Group AG	592,054	$1.86M	0.0%	+457.1%	0.361%
2/8/2023	Nordea Investment Management AB	673,398	$2.03M	0.0%	-1.3%	0.411%
2/8/2023	Swiss National Bank	321,260	$1.01M	0.0%	+9.7%	0.196%
2/8/2023	Arizona State Retirement System	37,549	$0.12M	0.0%	+10.8%	0.023%
2/7/2023	Handelsbanken Fonder AB	15,146	$48K	0.0%	N/A	0.009%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	69,610	$0.22M	0.0%	+12.8%	0.042%
2/6/2023	Los Angeles Capital Management LLC	18,076	$57K	0.0%	-83.3%	0.011%
2/6/2023	Banque Pictet & Cie SA	124,910	$0.39M	0.0%	-24.0%	0.076%
2/2/2023	SG Americas Securities LLC	52,130	$0.16M	0.0%	-29.8%	0.032%
2/2/2023	ProShare Advisors LLC	30,772	$97K	0.0%	+12.9%	0.019%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	31,670	$99K	0.0%	+23.5%	0.019%
1/30/2023	Signaturefd LLC	11,774	$37K	0.0%	+617.1%	0.007%
1/20/2023	DAVENPORT & Co LLC	78,100	$0.25M	0.0%	-31.2%	0.048%
1/18/2023	Vanguard Capital Wealth Advisors	10,180	$32K	0.0%	-27.2%	0.006%
1/12/2023	Assenagon Asset Management S.A.	864,440	$2.71M	0.0%	-1.0%	0.527%
11/15/2022	Federated Hermes Inc.	333,785	$1.64M	0.0%	-54.2%	0.204%
11/14/2022	Tudor Investment Corp Et Al	31,256	$0.15M	0.0%	-78.3%	0.019%
11/14/2022	Cubist Systematic Strategies LLC	218,429	$1.07M	0.0%	-48.9%	0.133%
11/14/2022	PDT Partners LLC	57,915	$0.28M	0.0%	-10.7%	0.035%
11/14/2022	Renaissance Technologies LLC	1,666,096	$8.16M	0.0%	+15.7%	1.017%
11/14/2022	Verition Fund Management LLC	12,622	$62K	0.0%	N/A	0.008%
11/14/2022	Penserra Capital Management LLC	43,877	$0.21M	0.0%	+264.2%	0.027%
11/14/2022	Nuveen Asset Management LLC	3,355,829	$16.44M	0.0%	+208.4%	2.048%
11/14/2022	AXA S.A.	291,800	$1.43M	0.0%	N/A	0.178%
11/14/2022	Hsbc Holdings PLC	52,297	$0.26M	0.0%	+15.6%	0.032%
11/14/2022	E Fund Management Co. Ltd.	27,723	$0.14M	0.0%	-12.2%	0.017%
11/14/2022	New Harbor Financial Group LLC	10,410	$51K	0.0%	N/A	0.006%
11/14/2022	Oppenheimer & Co. Inc.	47,000	$0.23M	0.0%	-38.6%	0.029%
11/14/2022	Brown Advisory Inc.	13,140	$64K	0.0%	-30.0%	0.008%
11/10/2022	Credit Suisse AG	3,803,127	$18.64M	0.0%	+0.3%	2.321%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	604,938	$2.96M	0.0%	+56.7%	0.369%
11/10/2022	ExodusPoint Capital Management LP	352,730	$1.73M	0.0%	+12.5%	0.215%
11/10/2022	Dimensional Fund Advisors LP	3,070,841	$15.05M	0.0%	-0.4%	1.874%
11/10/2022	Tower Research Capital LLC TRC	34,414	$0.17M	0.0%	+8.4%	0.021%
11/9/2022	Pinnacle Wealth Planning Services Inc.	24,098	$0.12M	0.0%	+37.6%	0.015%
11/9/2022	Massachusetts Financial Services Co. MA	418,562	$2.05M	0.0%	N/A	0.255%
11/9/2022	Aigen Investment Management LP	12,577	$62K	0.0%	N/A	0.008%
11/8/2022	KLK Capital Management LLC	44,323	$0.22M	0.3%	N/A	0.027%

Data available starting January 2016

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A; BIVV003, a zinc finger nuclease gene-edited cell therapy product candidate that is in Phase 1/2 PRECIZN-1 clinical study for the treatment of sickle cell disease. Its preclinical development products focus on CAR-Treg cell therapies for autoimmune disorders and genome engineering for neurological diseases. Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Richmond, California.

Today's Range

Now: $0.49

$0.49

$0.52

50 Day Range

MA: $0.81

$0.49

$1.38

52 Week Range

Now: $0.49

$0.29

$1.78

Volume

1,157,218 shs

Average Volume

2,197,619 shs

Market Capitalization

$102.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of Sangamo Therapeutics?: Sangamo Therapeutics' top insider shareholders include:
Biogen Inc (Major Shareholder)
John Markels (Director)
Learn More about top insider investors at Sangamo Therapeutics.
Who are the major institutional investors of Sangamo Therapeutics?: Sangamo Therapeutics' top institutional investors include:
Wasatch Advisors LP — 11.25%
Learn More about top institutional investors of Sangamo Therapeutics stock.
Which major investors are buying Sangamo Therapeutics stock?: During the last quarter, SGMO stock was bought by institutional investors including:
Wasatch Advisors LP

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SGMO Insider Trading

Sangamo Therapeutics Insider Trading History Chart

Sangamo Therapeutics Share Price & Price History

Sangamo Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Sangamo Therapeutics (NASDAQ:SGMO)

Institutional Buying and Selling by Quarter

Sangamo Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Sangamo Therapeutics?

Who are the major institutional investors of Sangamo Therapeutics?

Which major investors are buying Sangamo Therapeutics stock?